These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10583001)

  • 1. Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats.
    Callaway JK; Knight MJ; Watkins DJ; Beart PM; Jarrott B
    Stroke; 1999 Dec; 30(12):2704-12; discussion 2712. PubMed ID: 10583001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AM-36, a novel neuroprotective agent, profoundly reduces reactive oxygen species formation and dopamine release in the striatum of conscious rats after endothelin-1-induced middle cerebral artery occlusion.
    Callaway JK; Lawrence AJ; Jarrott B
    Neuropharmacology; 2003 May; 44(6):787-800. PubMed ID: 12681377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats.
    Gupta S; Sharma U; Jagannathan NR; Gupta YK
    Exp Neurol; 2017 Feb; 288():25-37. PubMed ID: 27794423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 1-antitrypsin therapy mitigated ischemic stroke damage in rats.
    Moldthan HL; Hirko AC; Thinschmidt JS; Grant MB; Li Z; Peris J; Lu Y; Elshikha AS; King MA; Hughes JA; Song S
    J Stroke Cerebrovasc Dis; 2014; 23(5):e355-63. PubMed ID: 24582784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of AM-36: a novel neuroprotective agent.
    Callaway JK
    Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):913-8. PubMed ID: 11703395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
    Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
    J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
    Li Q; Stephenson D
    Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat.
    Reglodi D; Somogyvari-Vigh A; Vigh S; Kozicz T; Arimura A
    Stroke; 2000 Jun; 31(6):1411-7. PubMed ID: 10835464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of CGS 26303, an endothelin-converting enzyme inhibitor, on transient middle cerebral artery occlusion in rats.
    Chang CZ; Yen CP; Winadi D; Wu SC; Howng SL; Lin TK; Jeng AY; Kassell NF; Kwan AL
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S487-9. PubMed ID: 15838355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term beneficial effects of BW619C89 on neurological deficit, cognitive deficit and brain damage after middle cerebral artery occlusion in the rat.
    Smith SE; Hodges H; Sowinski P; Man CM; Leach MJ; Sinden JD; Gray JA; Meldrum BS
    Neuroscience; 1997 Apr; 77(4):1123-35. PubMed ID: 9130792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies.
    Milani D; Bakeberg MC; Cross JL; Clark VW; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
    PLoS One; 2018; 13(3):e0193884. PubMed ID: 29513757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience.
    Aronowski J; Strong R; Shirzadi A; Grotta JC
    Stroke; 2003 May; 34(5):1246-51. PubMed ID: 12690223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed treatment with nicotinamide (Vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats.
    Mokudai T; Ayoub IA; Sakakibara Y; Lee EJ; Ogilvy CS; Maynard KI
    Stroke; 2000 Jul; 31(7):1679-85. PubMed ID: 10884473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death.
    Xu J; Culman J; Blume A; Brecht S; Gohlke P
    Stroke; 2003 May; 34(5):1287-92. PubMed ID: 12677021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PcTx1 affords neuroprotection in a conscious model of stroke in hypertensive rats via selective inhibition of ASIC1a.
    McCarthy CA; Rash LD; Chassagnon IR; King GF; Widdop RE
    Neuropharmacology; 2015 Dec; 99():650-7. PubMed ID: 26320544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium channel blocking activity of AM-36 and sipatrigine (BW619C89): in vitro and in vivo evidence.
    Callaway JK; Castillo-Melendez M; Giardina SF; Krstew EK; Beart PM; Jarrott B
    Neuropharmacology; 2004 Jul; 47(1):146-55. PubMed ID: 15165842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel, rapid, computerized method for quantitation of neuronal damage in a rat model of stroke.
    Callaway JK; Knight MJ; Watkins DJ; Beart PM; Jarrott B; Delaney PM
    J Neurosci Methods; 2000 Oct; 102(1):53-60. PubMed ID: 11000411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of stroke.
    Campbell CA; Barone FC; Benham CD; Hadingham SJ; Harries MH; Harling JD; Hills JM; Lewis VA; Mackay KB; Orlek BS; White RF; Parsons AA; Hunter AJ
    Eur J Pharmacol; 2000 Aug; 401(3):419-28. PubMed ID: 10936502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of low-intensity transcranial ultrasound stimulation in endothelin-1-induced middle cerebral artery occlusion in rats.
    Wu S; Zheng T; Du J; Yuan Y; Shi Q; Wang Z; Liu D; Liu J; Wang X; Liu L
    Brain Res Bull; 2020 Aug; 161():127-135. PubMed ID: 32439337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats.
    Meloni BP; Milani D; Cross JL; Clark VW; Edwards AB; Anderton RS; Blacker DJ; Knuckey NW
    Neuromolecular Med; 2017 Sep; 19(2-3):271-285. PubMed ID: 28523591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.